Gavine, P. R., Ren, Y., Han, L., Lv, J., Fan, S., Zhang, W., . . . Wang, Q. M. (2014). Volitinib, a potent and highly selective c‐Met inhibitor, effectively blocks c‐Met signaling and growth in c‐MET amplified gastric cancer patient‐derived tumor xenograft models. Mol Oncol.
استشهاد بنمط شيكاغوGavine, Paul R., et al. "Volitinib, a Potent and Highly Selective C‐Met Inhibitor, Effectively Blocks C‐Met Signaling and Growth in C‐MET Amplified Gastric Cancer Patient‐derived Tumor Xenograft Models." Mol Oncol 2014.
MLA استشهادGavine, Paul R., et al. "Volitinib, a Potent and Highly Selective C‐Met Inhibitor, Effectively Blocks C‐Met Signaling and Growth in C‐MET Amplified Gastric Cancer Patient‐derived Tumor Xenograft Models." Mol Oncol 2014.